To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

[Interferon-alpha can imp… - University of Gothenburg, Sweden Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

[Interferon-alpha can improve the prognosis in high-risk melanoma. Combination of surgery, cytostatics and natural IFN-alpha doubled the survival rate]

Journal article
Authors Örjan Strannegård
Fredrik Bergh Thorén
Erik Lundgren
Published in Läkartidningen
Volume 105
Issue 6
Pages 358-61
ISSN 0023-7205
Publication year 2008
Published at Institute of Biomedicine, Department of Infectious Medicine
Pages 358-61
Language en
Links www.ncbi.nlm.nih.gov/entrez/query.f...
Keywords Antineoplastic Agents, Alkylating, therapeutic use, Combined Modality Therapy, Dacarbazine, therapeutic use, Disease Progression, Humans, Immunologic Factors, therapeutic use, Interferon-alpha, therapeutic use, Melanoma, drug therapy, mortality, surgery, therapy, Survival Rate, Treatment Outcome
Subject categories Tumour immunology
Page Manager: Webmaster|Last update: 9/11/2012
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?